EUVIMEDEUVIMED entdecken
Editorial

Drug law versus common parlance of medicinal chemists on “new chemical entity” of novel drug designations

Sarah K Branch, Israel Agranat

Medicinal Chemistry Research · 2026-05 · 35 (5) · 863-866

DOI: 10.1007/s00044-026-03546-1 ↗

Kurz gefasst

Editorial in der Zeitschrift Medicinal Chemistry Research, online erschienen am 09.04.2026. Verfasst von Sarah K Branch und 1 weiteren Autor:innen. Beteiligte Einrichtung: , Gravesend, UK. sarahbranch2022@gmail.com. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Drug lawNew chemical entityNovel biological entityNovel drugNovel molecular entity

Autor:innen und Institutionen

  • , Gravesend, UK. sarahbranch2022@gmail.com.
  • Organic Chemistry, Institute of Chemistry, Philadelphia Building #212, Edmond J. Safra Campus, The Hebrew University of Jerusalem, Jerusalem, Israel. isri.agranat@mail.huji.ac.il.

Zitieren

APA

Branch, S. K., & Agranat, I. (2026). Drug law versus common parlance of medicinal chemists on “new chemical entity” of novel drug designations. Medicinal Chemistry Research, 35(5), 863-866. https://doi.org/10.1007/s00044-026-03546-1

Vancouver

Branch SK, Agranat I. Drug law versus common parlance of medicinal chemists on “new chemical entity” of novel drug designations. Medicinal Chemistry Research. 2026;35(5):863-866. doi:10.1007/s00044-026-03546-1

BibTeX
@article{Branch2026,
  author = {Branch, Sarah K and Agranat, Israel},
  title = {Drug law versus common parlance of medicinal chemists on “new chemical entity” of novel drug designations},
  journal = {Medicinal Chemistry Research},
  year = {2026},
  volume = {35},
  number = {5},
  pages = {863--866},
  doi = {10.1007/s00044-026-03546-1}
}
Kostenlos starten →